Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | Changing opinions on the use of biosimilars

Matti Aapro • 8 Sep 2017
ESMO 2017

Matti Aapro, MD, from the Multidisciplinary Oncology Institute, Genolier, Switzerland, discusses misconceptions by healthcare professionals about biosimilars at the European Society for Medical Oncology (ESMO) 2017 in Madrid, Spain. Registration for biosimilars is quite a complex process, and to be approved, they must prove that they are the same product as the originator. Using biosimilars reduces the cost, therefore increasing the availability and accessibility. There are still some misunderstandings about biosimilars, however, with more information, this will change.

More from Matti Aapro

Supportive care in cancer: more is needed
3:39
Supportive care in cancer: more is needed
Matti Aapro • 28 Sep 2019
NEPA to prevent chemotherapy-induced nausea and vomiting
2:15
NEPA to prevent chemotherapy-induced nausea and vomiting
Matti Aapro • 28 Sep 2019
How to manage elderly patients on immunotherapy
3:14
How to manage elderly patients on immunotherapy
Matti Aapro • 18 Jan 2019
Guidelines for adherence to CINV treatment
2:47
Guidelines for adherence to CINV treatment
Matti Aapro • 4 Jan 2019

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals